Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · IEX Real-Time Price · USD
43.09
+0.24 (0.56%)
Mar 28, 2024, 11:24 AM EDT - Market open

Total Valuation

SLNO has a market cap or net worth of $1.39 billion. The enterprise value is $1.22 billion.

Market Cap 1.39B
Enterprise Value 1.22B

Important Dates

The last earnings date was Wednesday, March 6, 2024, before market open.

Earnings Date Mar 6, 2024
Ex-Dividend Date n/a

Share Statistics

SLNO has 32.46 million shares outstanding. The number of shares has increased by 96.40% in one year.

Shares Outstanding 32.46M
Shares Change (YoY) +96.40%
Shares Change (QoQ) +44.20%
Owned by Insiders (%) 2.15%
Owned by Institutions (%) 97.15%
Float 13.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 8.83
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 14.89, with a Debt / Equity ratio of 0.00.

Current Ratio 14.89
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -79.70% and return on invested capital (ROIC) is -24.49%.

Return on Equity (ROE) -79.70%
Return on Assets (ROA) -52.90%
Return on Capital (ROIC) -24.49%
Revenue Per Employee n/a
Profits Per Employee -$1.18M
Employee Count 33
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +1,764.13% in the last 52 weeks. The beta is -1.52, so SLNO's price volatility has been lower than the market average.

Beta (1Y) -1.52
52-Week Price Change +1,764.13%
50-Day Moving Average 46.28
200-Day Moving Average 24.97
Relative Strength Index (RSI) 43.23
Average Volume (30 Days) 302,093

Short Selling Information

The latest short interest is 2.30 million, so 7.10% of the outstanding shares have been sold short.

Short Interest 2.30M
Short Previous Month 1.68M
Short % of Shares Out 7.10%
Short % of Float 17.44%
Short Ratio (days to cover) 7.51

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -38.67M
Pretax Income -38.99M
Net Income -38.99M
EBITDA -36.71M
EBIT -38.99M
Earnings Per Share (EPS) -$2.36
Full Income Statement

Balance Sheet

The company has $169.68 million in cash and $403,000 in debt, giving a net cash position of $169.28 million or $5.21 per share.

Cash & Cash Equivalents 169.68M
Total Debt 403,000
Net Cash 169.28M
Net Cash Per Share $5.21
Equity / Book Value 157.51M
Book Value Per Share 4.85
Working Capital 159.85M
Full Balance Sheet

Cash Flow

Operating Cash Flow -24.94M
Capital Expenditures n/a
Free Cash Flow -24.94M
FCF Per Share -$1.51
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SLNO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -96.40%
Shareholder Yield -96.40%
Earnings Yield -2.80%
FCF Yield -1.79%

Analyst Forecast

The average price target for SLNO is $55.60, which is 29.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target $55.60
Price Target Difference 29.47%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on August 26, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date Aug 26, 2022
Split Type Reverse
Split Ratio 1:15

Scores

Altman Z-Score n/a
Piotroski F-Score 2